Service Overview

Clinical research solutions for pharma, biotech and CROs.

Global Biomarker and Bioanalytical Solutions Specialist

Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

We offer a comprehensive range of services comprising the identification, development, validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research. Our global network of labs serve pharma and biotech customers directly or through a CRO, adhering to GCP/GLP/GMP guidelines.

Services

ProtoTrials®

ProtoTrials® is a proprietary human in vitro translational platform. ProtoTrials studies are adaptive and collaborative in nature and draw together vast scientific expertise, an extensive selection of technologies and customisable assays, along with access to a broad portfolio of samples from both healthy and diseased states.

Flow Cytometry

Flow Cytometry is core to Synexa’s positioning as a biomarker expert. We provide key expertise in the development and validation of complex assays, encompassing multimer staining, phospho-flow and target engagement assays.

Soluble Biomarkers

With decades of experience in biomarker strategies and assay development, our biomarker panels enhance decision-making in all stages of therapeutic clinical development.

Bioanalysis

We offer extensive experience in large molecule bioanalysis, developing and fully validating bespoke assays to support clinical sample analysis, following the latest FDA & EMA guidelines.

Tissue Imaging

Synexa’s specialised tissue and cell imaging services allow for the interrogation of multiple targets in in situ. Leveraging cutting edge technologies, we provide comprehensive and precise insights into spatial relationships in cells and tissues.

Biomarker Consulting

Leverage our expert team of in-house scientists to develop and implement optimal biomarker strategies. Integrative biomarker panels will provide crucial insights, improving the decision making process throughout clinical development of a therapeutic.

Therapeutic Expertise

We have experience in multiple therapeutic areas and continue to expand our knowledge base. Synexa’s global setup aims to support partners from preclinical translational research and biomarker development through to clinical bioanalysis of established and novel drug modalities.

Robust and Proven Platforms

Our technology platforms are robust, reliable and reputable in the clinical field and provide comprehensive and detailed data readouts for your application.

CytoFLEX (13 colours)

Platform

BD FACSCanto II (8 colours)

Platform

BD FACSymphony A3 (28 colours)

Platform

Revvity Wizard² Gamma Counter

Platform

Olink®Signature Q100

Platform

illumina iSeq100

Platform

Discuss Real Solutions to Develop Your Therapeutic Pipeline

Bridging the gap between science and life.